Crispin Blunt’s drug policy unit loses thousands of taxpayer money
The IndependentSign up for the View from Westminster email for expert analysis straight to your inbox Get our free View from Westminster email Get our free View from Westminster email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Crispin Blunt’s drug policy group that sought to reclassify magic mushrooms and cannabis owes thousands of pounds to the taxpayer after closing down. The CDPRG aimed to allow access to cannabis-based medical products and reform wider drug policy following the “current failure of prohibition”. A spokesman for the British Business Bank, which administers the fund, told The Telegraph: “The Future Fund was created at the height of the pandemic to ensure a flow of capital to companies that would otherwise have been unable to access government support schemes, while ensuring long-term value for the UK taxpayer. “As venture capital is long-term investment, it is too early to give an indication of the overall Future Fund performance, however due to the size of the portfolio, and the commercial nature of the third-party investors, we expect it to track the market over time.” Crispin Blunt did not respond to a request for comment from The Independent.
Discover Related
